美联社西雅图2021年1月29日电，Atossa Therapeutics，Inc.（纳斯达克股票代码：ATOS）首席执行官史蒂文奎伊（Steven Quay）博士今天发表了一篇论文，题为“贝叶斯分析得出结论：毫无疑问SARS-CoV-2不是从自然界传播给人和动物，而是来自一家实验室。” 可以从Zenodo（这是由CERN运营的通用开放存取存储库）下载193页的论文，网址为：https://zenodo.org/record/4477081#。 有关该论文的简短“解释性视频”在这里：https：//zenodo.org/record/4477212#。
该分析旨在确定引起COVID-19的病毒SARS-CoV-2的来源。该研究从病毒是从自然界转播给人与动物的可能性为98.2％、从实验室逃逸的可能性仅有1.2％开始，系统地分析了26种不同的独立事实和证据，最终的结论是，SARS-CoV-2来自实验室的可能性为99.8％，而来自自然界的可能性只有0.2％。
奎伊博士表示，“与其他许多人一样，我担心世卫组织研究小组成员与中国科学家和医生之间似乎存在重大利益冲突，以及在多大程度上会阻碍对SARS-CoV-2起源的公正调查，”
“仅仅通过公开获得的关于SARS-CoV-2的科学证据，并在我的分析中使用高度保守的估计，我得出的结论是，SARS-CoV-2毫无疑问是从一家实验室逃逸出来的。 另外，从2019年12月起，武汉病毒研究所的5例患者的标本中似乎存在腺病毒疫苗基因序列，这一证据需要做出解释。 例如，你们会在疫苗挑战试验中看到此类数据， 希望世卫组织团队能够得到这些问题的答案。”
为了帮助找到真相并获得对本文使用的方法和结论的反馈意见，作者已向世界各地的26位科学家发送了该论文的预印本，包括目前在武汉的WHO研究人员、武汉病毒学研究所 科学家以及其他杰出的病毒学家。
关于史蒂芬·奎伊（医学博士）
史蒂芬·奎伊（Steven Quay）博士已发表360余篇关于医学的论文，被引用了10,000多次，使他跻身于全球科学家的前1％之列。他拥有87项美国专利，发明了7种经过FDA批准的药物，为8000万人提供了帮助。他是畅销书《幸存大流行：保持安全：冠状病毒生存医生指南》的作者。他是Atossa Therapeutics Inc.（纳斯达克股票代码：ATOS）的首席执行官，这是一家制造临床药物的生物制药公司，致力于开发治疗乳腺癌和COVID-19的新型疗法。
他在密西根大学获医学博士学位和PhD，在麻省理工学院化学系担任博士后，与哈佛大学MGH医院住院医师、诺贝尔奖获得者H. Gobind Khorana一起工作，在斯坦福大学医学院任教近十年。他发表的关于预防乳腺癌的TEDx演讲已被观看220,000多次。欲了解更多信息，请访问www.DrQuay.com
New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory
SEATTLE, Jan. 29, 2021 /PRNewswire/ -- A paper was published today by Dr. Steven Quay, M.D., PhD., CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS), entitled, “A Bayesian analysis concludes beyond a reasonable doubt that SARS-CoV-2 is not a natural zoonosis but instead is laboratory derived.” The 193-page paper can be downloaded from Zenodo, a general-purpose open-access repository operated by CERN, here: https://zenodo.org/record/4477081# . A short ‘explainer’ video about the paper is here: https://zenodo.org/record/4477212#.
The purpose of the analysis was to determine the origin of SARS-CoV-2, the virus that causes COVID-19. Beginning with a likelihood of 98.2% that it was a zoonotic jump from nature with only a 1.2% probability it was a laboratory escape, twenty-six different, independent facts and evidence were examined systematically. The final conclusion is that it is a 99.8% probability SARS-CoV-2 came from a laboratory and only a 0.2% likelihood it came from nature.
“Like many others, I am concerned about what appear to be significant conflicts of interest between members of the WHO team and scientists and doctors in China and how much this will impede an unbiased examination of the origin of SARS-CoV-2,” said Dr. Quay.
“By taking only publicly available, scientific evidence about SARS-CoV-2 and using highly conservative estimates in my analysis, I nonetheless conclude that it is beyond a reasonable doubt that SARS-CoV-2 escaped from a laboratory. The additional evidence of what appears to be adenovirus vaccine genetic sequences in specimens from five patients from December 2019 and sequenced by the Wuhan Institute of Virology requires an explanation. You would see this kind of data in a vaccine challenge trial, for example. Hopefully the WHO team can get answers to these questions.”
To assist in finding the truth and to get feedback on the methodologies used and conclusions reached in this paper, a pre-publication copy of this paper was sent to twenty-six scientists worldwide, including the WHO investigators currently in Wuhan, Wuhan Institute of Virology scientists, as well as other prominent virologists.
About Steven Quay, M.D., Ph.D.
Dr. Steven Quay has 360+ published contributions to medicine and has been cited over 10,000 times, placing him in the top 1% of scientists worldwide. He holds 87 US patents and has invented seven FDA-approved pharmaceuticals which have helped over 80 million people. He is the author of the best-selling book on surviving the pandemic, Stay Safe: A Physician’s Guide to Survive Coronavirus. He is the CEO of Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics for treating breast cancer and COVID-19.
He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow in the Chemistry Department at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and spent almost a decade on the faculty of Stanford University School of Medicine. A TEDx talk he delivered on breast cancer prevention has been viewed over 220,000 times. For more information, visit www.DrQuay.com
